FDA Adverse Event Malfunction Summary report: N

UREA/BUN

MDR report key: 24930868 · Received April 20, 2026

Report

Report Number
1823260-2026-01502
Event Type
Malfunction
Date Received
April 20, 2026
Date of Event
March 25, 2026
Report Date
May 13, 2026
Manufacturer
ROCHE DIAGNOSTICS
Product Code
CDQ
UDI-DI
04015630925131
PMA / PMN Number
K972250
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
EG
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE ANALYZER SERIAL NUMBER IS (B)(6). THE CALIBRATION AND CONTROL RECOVERY DATA PROVIDED WAS WITHIN SPECIFICATION. THE ALARM TRACE SHOWED ABNORMAL CELL BLANK, LOW PRESSURE IN THE VACUUM TANK, AND SAMPLE SHORT ALARMS. THE FIELD SERVICE ENGINEER (FSE) CHECKED THE SAMPLE AND REAGENT PROBES, GEAR PUMP PRESSURES, AND RINSE VOLUMES, AND PERFORMED A MECHANICAL CHECK SUCCESSFULLY. THE INVESTIGATION IS ONGOING.

Additional Manufacturer Narrative · 0

BASED ON THE CALIBRATION AND QC DATA, A GENERAL REAGENT ISSUE COULD BE EXCLUDED. THE SERVICE MAINTENANCE ACTIONS PERFORMED BY THE FSE RESOLVED THE ISSUE. NO FURTHER ISSUES WERE REPORTED AFTER THE SERVICE VISIT. THE INVESTIGATION DID NOT IDENTIFY A PRODUCT PROBLEM. THE ROOT CAUSE OF THE EVENT COULD NOT BE DETERMINED.

Description of Event or Problem · 0

THERE WAS AN ALLEGATION OF QUESTIONABLE LOW UREA/BUN RESULTS FOR 3 PATIENT SAMPLES ON A COBAS 8000 C702 MODULE. SAMPLE 1 HAD AN INITIAL RESULT OF 1.2 MG/DL. THE SAMPLE WAS REPEATED ON A SIEMENS ANALYZER AND THE RESULT WAS 41 MG/DL. SAMPLE 2 HAD AN INITIAL RESULT OF 1.8 MG/DL. THE SAMPLE WAS REPEATED ON A SIEMENS ANALYZER AND THE RESULT WAS 28 MG/DL. SAMPLE 3 HAD AN INITIAL RESULT OF 2.6 MG/DL. THE SAMPLE WAS REPEATED ON A SIEMENS ANALYZER AND THE RESULT WAS 62 MG/DL. NO QUESTIONABLE RESULTS WERE REPORTED OUTSIDE OF THE LABORATORY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
404988 UREA/BUN UREA NITROGEN TEST SYSTEM CDQ ROCHE DIAGNOSTICS 89811001 04015630925131

Patients

Seq Age Sex Outcome Treatment
1